Lilly R-Fluoxetine Development Plan Relies On Prozac Exclusivity Until 2004

Lilly's development timetable for a single-isomer replacement for its antidepressant Prozac (fluoxetine) relies on delaying generic competition beyond the first fluoxetine patent expiration in 2001.